Европейский рынок лечения алопеции (выпадения волос) – тенденции отрасли и прогноз до 2030 года

 Анализ и размер европейского рынка лечения алопеции (выпадения волос)

С каждым десятилетием выпадение волос становится все более распространенным из-за нездоровых привычек питания и малоподвижного образа жизни. Кроме того, выпадение волос вызвано старением и гормональным дисбалансом, а также ростом хронических заболеваний, включая рак, гипертонию, артрит и депрессию, в основном среди населения среднего возраста. По данным Американской ассоциации по борьбе с выпадением волос, андрогенная алопеция является причиной почти 95% случаев выпадения волос у мужчин. Более 800 000 человек ищут решение проблемы выпадения волос.

Data Bridge Market Research анализирует темпы роста рынка лечения алопеции (выпадения волос) в прогнозируемый период 2023–2030 гг. Ожидаемый среднегодовой темп роста рынка лечения алопеции (выпадения волос) составляет около 6,70% в указанный прогнозируемый период. Рыночная стоимость составляет 1005,4 млн долларов США в 2022 году и вырастет до 1689,10 млн долларов США к 2030 году. Помимо таких рыночных данных, как рыночная стоимость, темпы роста, сегменты рынка, географический охват, участники рынка и рыночный сценарий, рыночный отчет, подготовленный командой Data Bridge Market Research, также включает в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ конвейера, анализ цен и нормативную базу.

Объем и сегментация европейского рынка лечения алопеции (выпадения волос)

Market Definition

With the increasing hair fall issues, there is a huge rise in demand for hair loss treatment products all over the world. There is rising awareness that hair loss treatment can help to avoid hair loss and revive hair growth. Alopecia is a kind of hair loss that is caused by particular medical illnesses or nutritional disorders. Hair loss is becoming more prevalent due to sedentary lifestyles and unhealthy eating habits. As per the American Hair Loss Association, androgenetic alopecia results for approximately 95% of hair loss in men.

Europe Alopecia Treatment (Hair Loss) Market Dynamics

Drivers

• Increasing Incidence of Hair Loss

The increasing prevalence of hair loss is projected to boost the growth of the alopecia treatment (hair loss) market. For instance, around half of the men get bald at 42.79%, baldness is very common in the Czech Republic. Furthermore, spain is on the second-highest number in hair losing men at 42.6% which Germany follows with 41.2% of men losing their hair further followed by France with 39.24%. Additionally, nearly 2% of the entire population, irrespective of gender, is at high risk of acquiring alopecia treatment (hair loss) in their lifetime. Further statistics from health departments witness that Europe’s urban residents' consumption of hair care is increasing each year at an increasing pace of 30 %, which over the upcoming years, is anticipated to increase the hair nutrition, restoration, and transplantation business. Nevertheless, 8 out of 10 countries with the significant and maximum hair-loss issues are European nations. Thus, it boosts the market growth.

Opportunities

• Wide Adoption of Platelet-Rich Plasma Therapy

Increasing adoption of platelet-rich plasma therapy is anticipated to offer huge growth opportunities for players in the market. For instance, several researchers from Plastic and Reconstructive Surgery, “Tor Vergata” University, Italy, stated that platelet-rich plasma is considered a safe and effective alternative to treat hair loss compared with Minoxidil and Finasteride in April 2020. Thus, this boosts the market growth.   

• Increasing Adoption of Organic Hair Products

Traditional natural and herbal based products are more incident for the treatment of hair loss problems in countries such as India and China. The organic hair loss products are most likely to be pushed by males, because they are more susceptible to hair losses. In general, the hair type among Asians is not quite as vulnerable to genetic thinning as western hair, but that affects a million men and women with hair loss. Thus, it increases the market growth.

Restraints/Challenges

• Limited Efficacy of Hair Loss Drugs

Limited efficacy and lack of evidence suggest that clinical efficacy of the existing hair loss drugs is hindering market growth. For instance, current topical hair loss treatments are widely available in the market such as minoxidil are not 100% effective for the treatment of alopecia, although it has been clinically proven to decrease the progression of hair loss.

• Lack of Reimbursement Policies

There is a lack of reimbursement for hair loss treatment services, which are expected to restrict the market growth. Both public and private payers do not reimburse majority of the laser treatment services. The cost of such services varies greatly and there cannot be any standardization.

This alopecia treatment (hair loss) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the alopecia treatment (hair loss) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2022, Clariant Natural Ingredients launched Prunizen, a new natural “feel good” active with the goal of treating stress-induced hair loss, enhancing the vitality of the hair and density, and confirming the well-being of the hair and scalp.
• In 2021, Procter & Gamble acquired a haircare and lifestyle brand, Ouai, founded by beauty influencer and celebrity hairstylist Jen Atkin.
• In 2021, TRESemmé  launched a new line of natural hair care products in the U.K. named Pro Pure. The range included three shampoo and conditioner pairs: Damage Recovery, Radiant Color, and Airlight Volume.

Europe Alopecia Treatment (Hair Loss) Market Scope

The alopecia treatment (hair loss) market is segmented on the basis of disease type, treatment, gender, form, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Disease Type

• Non‒Cicatricial Alopecia
• Traction Alopecia
• Ciatricial Alopecia
• Others

Treatment

• Localized Therapies
• Medical Devices
• Systemic Therapies
• Herbal Treatment

Gender

• Male
• Female

Form

• Topical
• Oral
• Parenteral

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Alopecia Treatment (Hair Loss) Regional Analysis/Insights

The alopecia treatment (hair loss) market is analyzed and market size insights and trends are provided by disease type, treatment, gender, form, end user and distribution channel as referenced above.

The major countries covered in the alopecia treatment (hair loss) market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.

Germany is leading the market growth rate due to the increased awareness among the population about the huge benefits of natural and organic products and the wide effects of harmful chemicals in the existing ones. Besides that, the rise in the population stating the issue or problem of hair loss among them is also driving the market's growth.   

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Competitive Landscape and Europe Alopecia Treatment (Hair Loss) Share Analysis

The alopecia treatment (hair loss) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to alopecia treatment (hair loss) market

Key players operating in the alopecia treatment (hair loss) market include:

• Johnson & Johnson Private Limited (U.S.)
• GSK plc (U.K.)
• Merck & Co., Inc. (U.S.)
• Pfizer Inc. (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Cipla Inc. (U.S.)
• Endo International plc (Ireland)
• Zydus Group (India)
• Abbott (U.S.)
• Aurobindo Pharma (India)
• Dr. Reddy's Laboratories Ltd. (Индия)
• Perrigo Company plc (Ирландия)
• Curallux, LLC. (США)
• DR. KURT WOLFF GMBH & CO. KG (Германия)
• ВОКХАРДТ (Индия)

SKU-57063